|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 08983 | Phase III study of Tomudex and Cisplatin versus Cisplatin in Malignant Pleural Mesothelioma. |
| 08992 | Phase II study on Tomudex in malignant mesothelioma. |
| 08976 | Phase II study: Temozolomide in malignant mesothelioma |
| 08966 | Phase II study on Caelyx in malignant mesothelioma. |
| 08943 | Gemcitabine in malignant mesothelioma : a phase II study |
| 08924 | A phase II study of Taxol in mesothelioma |
| 08878 | Phase II study of etoposide in malignant mesothelioma |
| 08031 | Phase II feasibility trial of induction chemotherapy followed by extrapleural pneumonectomy and postoperative radiotherapy in patients with malignant pleural mesothelioma |
| 08052 | Phase II study of bortezomib with cisplatin as first line treatment of malignant mesothelioma |